FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Insiders Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

Real-time Estimate Tradegate Other stock markets 01:30:01 29/05/2024 am IST			5-day change	1st Jan Change
17.8 ^EUR	-6.81%		-3.73%	+70.99%

15/05	TD Cowen Starts NewAmsterdam Pharma With Buy Rating	MT
09/05	Earnings Flash (NAMS) NEWAMSTERDAM PHARMA N.V. Reports Q1 Revenue $1.4M	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NewAmsterdam Pharma Names Juliette Audet Chief Business Officer	01/04	MT
Newamsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer	01/04	CI
Newamsterdam Pharma Insider Sold Shares Worth $4,095,234, According to a Recent SEC Filing	28/03	MT
NewAmsterdam Pharma Company N.V. Announces Board Changes	08/01	CI
NewAmsterdam Pharma Appoints Ian Somaiya as Chief Financial Officer	23/23/23	MT
NewAmsterdam Pharma Announces Appointment of Ian Somaiya as Chief Financial Officer	23/23/23	CI
NewAmsterdam Pharma Appoints William Jones as First Chief Commercial Officer	15/23/15	MT
NewAmsterdam Pharma Company N.V. Appoints William ?BJ" Jones as Chief Commercial Officer	15/23/15	CI
NewAmsterdam Pharma Company Appoints Janneke van der Kamp to its Board of Directors	03/23/03	CI
NewAmsterdam Pharma Company N.V. Appoints John W. Smither as Independent Director	06/23/06	CI
NewAmsterdam Pharma Names David Topper CFO	20/22/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer